Controllable Immunosuppression in Pigs as a Basis for Preclinical Studies on Human Cell Therapy
Authors:
- Shin EnosawaSEShin Enosawa
- Eiji KobayashiEKEiji Kobayashi
Open Access
- 11 March 2020
- book chapter
- Published by IntechOpen
Abstract
Along with a growing interest in regenerative medicine, pigs are becoming a popular model for preclinical studies on human cell therapy. Due to pharmaceutical species difference and inability to self-medicate, specific modification and care are necessary in immunosuppressive regimen for pigs. Here, we summarize recent literature on immunosuppression in pigs for experimental transplantation. Based on literature and our own experiences, a practical protocol has been proposed in this report. In early studies of allogeneic organ transplantation, recipient pigs were administered cyclosporine or tacrolimus, and mycophenolate mofetil at slightly higher dose than that in human cases, because of relatively poor effectiveness of the drugs in pigs. Steroids may be effective but sometimes can cause debilitating side effects. Cell transplantation studies follow the basic protocol, but it remains to be clarified whether the smaller graft mass, even if it is xenogeneic, requires the same scale of immunosuppression as organ transplantation. To obtain reliable results, the use of gastrostomy tube and blood trough level monitoring are highly recommended. Nonpharmaceutical immunosuppression such as thymic intervention and the use of severe combined immunodeficient pigs have also been discussed.Keywords
This publication has 27 references indexed in Scilit:
- Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy ModelCirculation, 2012
- Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cellsThe International Journal of Cardiovascular Imaging, 2009
- Transplanted human cord blood-derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarctionHeart, 2008
- Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombinationJournal of Hepatology, 2007
- Effects of Mycophenolate Mofetil on Cardiac Allograft Survival and Cardiac Allograft Vasculopathy in Miniature SwineThe Annals of Thoracic Surgery, 2005
- INDUCTION OF TRANSPLANTATION TOLERANCE WITH A SHORT COURSE OF TACROLIMUS(FK506)Transplantation, 2001
- Long-term survival of an extremity composite tissue allograft with FK506–mycophenolate mofetil therapySurgery, 1999
- ROLE OF THE THYMUS IN TRANSPLANTATION TOLERANCE IN MINIATURE SWINETransplantation, 1999
- LONG-TERM COMPOSITE TISSUE ALLOGRAFT SURVIVAL IN A NOVEL PORCINE MODEL WITH CYCLOSPORINE (CSA)/MYCOPHENOLATE MOFETIL (MMF) THERAPYTransplantation, 1998
- COMBINED IMMUNOSUPPRESSIVE THERAPY WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL FOR SMALL BOWEL TRANSPLANTATION IN PIGS1Transplantation, 1996